Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer -- Ignore unavailable to you. Want to Upgrade?

To: WTDEC who wrote (836)	3/24/1998 6:18:00 PM
From: Russian Bear	Respond to of 1826

Walter, I wish I knew what is going on. All I can offer is the standard speculation of an impending release of news about the selection of a European partner for 114 or (less likely) the start of Phase II trials. This move does have the feel of one that will last, I have to say. (Muti-day, high volume, etc.) I increased my position by another 70%, over the last two days. Ordinarily, I do not buy immediately after substantial appreciation, but I made an exception in this case because MOGN is still so egregiously undervalued. Good luck, RB